Last reviewed · How we verify

Intralipid 20%

Emory University · FDA-approved active Small molecule Quality 5/100

Intralipid 20% is a Small molecule drug developed by Emory University. It is currently FDA-approved. Also known as: 20% I.V. Fat Emulsion, Lipid Emulsion 20%, Lipofundin 20%, soybean oil.

At a glance

Generic nameIntralipid 20%
Also known as20% I.V. Fat Emulsion, Lipid Emulsion 20%, Lipofundin 20%, soybean oil, N-6 polyunsaturated fatty acids atty acids
SponsorEmory University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intralipid 20%

What is Intralipid 20%?

Intralipid 20% is a Small molecule drug developed by Emory University.

Who makes Intralipid 20%?

Intralipid 20% is developed and marketed by Emory University (see full Emory University pipeline at /company/emory-university).

Is Intralipid 20% also known as anything else?

Intralipid 20% is also known as 20% I.V. Fat Emulsion, Lipid Emulsion 20%, Lipofundin 20%, soybean oil, N-6 polyunsaturated fatty acids atty acids.

What development phase is Intralipid 20% in?

Intralipid 20% is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing